Company Description
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide.
The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.
It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets.
The company was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
| Country | HI |
| Founded | 1983 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 86 |
| CEO | Matthew Keith Custer |
Contact Details
Address: 73-4460 Queen Kaahumanu Hwy, Suite 102 Kailua Kona, Hawaii 96740 United States | |
| Phone | 8083261353 |
| Website | cyanotech.com |
Stock Details
| Ticker Symbol | CYAN |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0000768408 |
| CUSIP Number | 232437301 |
| ISIN Number | BMG7403L1046 |
| Employer ID | 91-1206026 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Matthew Keith Custer | President, Chief Executive Officer and Director |
| Dr. Gerald R. Cysewski Ph.D. | Co-Founder, Chief Executive Officer Emeritus and Chief Scientific Officer |
| Felicia I. Ladin | Chief Financial Officer and Vice President of Finance & Administration and Treasurer |
| Glenn D. Jensen | Vice President of Operations |
| Charles J. Hartmann | Vice President of Sales and Marketing |
| Amy Beth Nordin | Vice President of Human Resources and Corporate Secretary |
| Collette Kakuk | Chief Strategic and Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 9, 2024 | 25-NSE | Filing |
| Feb 14, 2024 | 8-K | Current Report |
| Feb 8, 2024 | 10-Q | Quarterly Report |
| Dec 20, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Dec 19, 2023 | 8-K | Current Report |
| Nov 8, 2023 | 10-Q | Quarterly Report |
| Aug 30, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Aug 29, 2023 | 8-K | Current Report |
| Aug 29, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Aug 29, 2023 | SC 13D | General statement of acquisition of beneficial ownership |